PCBMI

Total 131
¹øÈ£ Á¦   ¸ñ ±Û¾´ÀÌ ³¯Â¥ Á¶È¸
°øÁö Æ÷½ºÅØ-°¡Å縯´ë ÀÇ»ý¸í°øÇבּ¸¿ø °³ÀÎÁ¤º¸Ã³¸®¹æÄ§ Á¦Á¤ °øÁö ÃÖ°í°ü¸®ÀÚ 2021-03-25 339
°øÁö [°ø°í] 2021³â Æ÷½ºÅØ-°¡Å縯´ë °øµ¿¿¬±¸Áö¿ø»ç¾÷(¿¬±¸È¸) °ø°í<~2/26(±Ý)> ÃÖ°í°ü¸®ÀÚ 2021-02-08 681
86 ¾ç»ê ºÎ»ê´ëÇб³º´¿ø ȲÅÂÈ£ ±³¼ö ÃÊû ¼¼¹Ì³ª °³ÃÖ (Æ÷-°¡¿¬±¸¿ø ±âȹÇÁ·ÎÁ§Æ®ÆÀ ÁÖ°ü) ÃÖ°í°ü¸®ÀÚ 2016-05-24 2164
85 [Á¦6È£] POCAPIA : Æ÷½ºÅØ-°¡Å縯´ë ÀÇ»ý¸í°øÇבּ¸¿ø À¥Áø ÃÖ°í°ü¸®ÀÚ 2016-05-16 2105
84 ¼­¿ï´ë Á¤¿¬¼® ±³¼ö ÃÊû ¼¼¹Ì³ª °³ÃÖ (Æ÷-°¡¿¬±¸¿ø ±âȹÇÁ·ÎÁ§Æ®ÆÀ ÁÖ°ü) ÃÖ°í°ü¸®ÀÚ 2016-04-14 2211
83 Æ÷½ºÅØ ½Å±ÙÀ¯ ±³¼ö ÃÊû ¼¼¹Ì³ª °³ÃÖ (Æ÷-°¡¿¬±¸¿ø ±âȹÇÁ·ÎÁ§Æ®ÆÀ ÁÖ°ü) ÃÖ°í°ü¸®ÀÚ 2016-04-14 2090
82 2016³â Æ÷½ºÅØ-°¡Å縯´ë °øµ¿¿¬±¸ Áö¿ø»ç¾÷ °ø°í(~3/11) ÃÖ°í°ü¸®ÀÚ 2016-02-22 2451
81 ÇϹöµå´ë Peter M. Kang ±³¼ö ÃÊû ¼¼¹Ì³ª °³ÃÖ ÃÖ°í°ü¸®ÀÚ 2016-02-19 2362
80 Á¤¼ºÁØ ±³¼ö ÃÊû ¼¼¹Ì³ª °³ÃÖ ÃÖ°í°ü¸®ÀÚ 2016-01-20 2568
79 '2015 Æ÷½ºÅØ-°¡Å縯´ë ¿¬±¸È¸ ¹ßǥȸ' °³ÃÖ ¾È³» ÃÖ°í°ü¸®ÀÚ 2016-01-15 2039
78 ¼ÛÁöȯ ±³¼ö ÃÊû ¼¼¹Ì³ª °³ÃÖ ÃÖ°í°ü¸®ÀÚ 2015-12-09 2347
77 Æ÷-°¡¿¬±¸¿ø ¼³¸³ 10Áֳ⠱â³äÇà»ç ¾È³» ÃÖ°í°ü¸®ÀÚ 2015-11-19 2410
76 ¿ÀÀÏȯ, ÀÌÁ¾¿ø ±³¼ö ÃÊû ¼¼¹Ì³ª °³ÃÖ (Æ÷½ºÅØ »ý¸í°øÇבּ¸¼¾ÅÍ) ÃÖ°í°ü¸®ÀÚ 2015-11-18 2303
75 ±èÂùÇõ ¹Ú»ç ÃÊû¼¼¹Ì³ª °³ÃÖ ¾È³»_(ÁÖ)À¯Æ¿·º½º ÁÖ°ü ÃÖ°í°ü¸®ÀÚ 2015-11-10 4034
74 À¯ÁÖ¿¬ ±³¼ö ÃÊû ¼¼¹Ì³ª °³ÃÖ ÃÖ°í°ü¸®ÀÚ 2015-11-05 3227
73 [Symposium] Mini-Symposium for Cancer Immunotherapy ÃÖ°í°ü¸®ÀÚ 2015-11-03 2228
72 [Á¦5È£] POCAPIA : Æ÷½ºÅØ-°¡Å縯´ë ÀÇ»ý¸í°øÇבּ¸¿ø À¥Áø ÃÖ°í°ü¸®ÀÚ 2015-11-03 2386
 1  2  3  4  5  6  7  8  9  

Á¦¸ñ ¾øÀ½